BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12740576)

  • 1. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.
    Zompi S; Hamerman JA; Ogasawara K; Schweighoffer E; Tybulewicz VL; Di Santo JP; Lanier LL; Colucci F
    Nat Immunol; 2003 Jun; 4(6):565-72. PubMed ID: 12740576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway.
    Billadeau DD; Upshaw JL; Schoon RA; Dick CJ; Leibson PJ
    Nat Immunol; 2003 Jun; 4(6):557-64. PubMed ID: 12740575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2D triggers cytotoxicity in murine epidermal γδ T cells via PI3K-dependent, Syk/ZAP70-independent signaling pathway.
    Ibusuki A; Kawai K; Yoshida S; Uchida Y; Nitahara-Takeuchi A; Kuroki K; Kajikawa M; Ose T; Maenaka K; Kasahara M; Kanekura T
    J Invest Dermatol; 2014 Feb; 134(2):396-404. PubMed ID: 23962808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.
    Jiang K; Zhong B; Gilvary DL; Corliss BC; Vivier E; Hong-Geller E; Wei S; Djeu JY
    J Immunol; 2002 Apr; 168(7):3155-64. PubMed ID: 11907067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases.
    Colucci F; Schweighoffer E; Tomasello E; Turner M; Ortaldo JR; Vivier E; Tybulewicz VL; Di Santo JP
    Nat Immunol; 2002 Mar; 3(3):288-94. PubMed ID: 11836527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
    Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
    J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.
    Huntington ND; Xu Y; Nutt SL; Tarlinton DM
    J Exp Med; 2005 May; 201(9):1421-33. PubMed ID: 15867094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment.
    Rabot M; El Costa H; Polgar B; Marie-Cardine A; Aguerre-Girr M; Barakonyi A; Valitutti S; Bensussan A; Le Bouteiller P
    Int Immunol; 2007 Apr; 19(4):401-9. PubMed ID: 17307798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
    Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells.
    Pisegna S; Zingoni A; Pirozzi G; Cinque B; Cifone MG; Morrone S; Piccoli M; Frati L; Palmieri G; Santoni A
    J Immunol; 2002 Jul; 169(1):68-74. PubMed ID: 12077230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
    Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
    J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses.
    Brumbaugh KM; Pérez-Villar JJ; Dick CJ; Schoon RA; López-Botet M; Leibson PJ
    J Immunol; 1996 Oct; 157(7):2804-12. PubMed ID: 8816383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45.
    Mason LH; Willette-Brown J; Taylor LS; McVicar DW
    J Immunol; 2006 Jun; 176(11):6615-23. PubMed ID: 16709819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
    Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
    J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redundant role of the Syk protein tyrosine kinase in mouse NK cell differentiation.
    Colucci F; Turner M; Schweighoffer E; Guy-Grand D; Di Bartolo V; Salcedo M; Tybulewicz VL; Di Santo JP
    J Immunol; 1999 Aug; 163(4):1769-74. PubMed ID: 10438908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase.
    McVicar DW; Taylor LS; Gosselin P; Willette-Brown J; Mikhael AI; Geahlen RL; Nakamura MC; Linnemeyer P; Seaman WE; Anderson SK; Ortaldo JR; Mason LH
    J Biol Chem; 1998 Dec; 273(49):32934-42. PubMed ID: 9830044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.
    Upshaw JL; Arneson LN; Schoon RA; Dick CJ; Billadeau DD; Leibson PJ
    Nat Immunol; 2006 May; 7(5):524-32. PubMed ID: 16582911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells.
    Palmieri G; Tullio V; Zingoni A; Piccoli M; Frati L; Lopez-Botet M; Santoni A
    J Immunol; 1999 Jun; 162(12):7181-8. PubMed ID: 10358164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKG2D and cytotoxic effector function in tumor immune surveillance.
    Hayakawa Y; Smyth MJ
    Semin Immunol; 2006 Jun; 18(3):176-85. PubMed ID: 16675266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.